Colorectal Cancer Screening Discontinuation Ages

Primary Stopping Age (75 years)

The U.S. Multi‑Society Task Force, USPSTF, American College of Gastroenterology, and American Cancer Society all recommend stopping routine colorectal cancer screening at age 75 for average‑risk adults who are up‑to‑date with prior testing. Grade A recommendation for ages 50‑75; after 75 the net benefit diminishes. 1

A life expectancy of less than 10 years is an absolute threshold for discontinuing colorectal cancer screening, regardless of the patient’s chronological age. This reflects the lag between detection and mortality benefit. 2

For adults aged 76‑85, screening should be offered selectively and is most appropriate for individuals who have never been previously screened.
Decision‑making in this age range must consider:
The NCCN (2024) specifically emphasizes that never‑screened individuals aged 76‑85 with good health and >10‑year life expectancy are most likely to benefit from screening. 4

All major guideline bodies (USPSTF, American College of Gastroenterology, American Cancer Society, U.S. Multi‑Society Task Force, NCCN, and others) recommend discontinuing colorectal cancer screening after age 85. 5
After age 85, the potential harms and adverse events of colonoscopy and follow‑up procedures outweigh any possible life‑expectancy benefit. 6

Do not continue routine screening in patients aged 75 or older solely because they are “healthy for their age.” Evidence shows diminishing returns even in healthier older adults who are up‑to‑date with screening. 1
Avoid initiating new screening in patients over 75 who have been consistently screened with negative results, as the yield is extremely low and the risk of harm increases. 2
The only exception is a never‑screened patient aged 76‑85 with good health and a life expectancy > 10 years, where selective screening may be reasonable. 4

In adults aged 76–85 years, the decision to continue colorectal cancer (CRC) screening should be based on three critical factors: (1) prior screening history, (2) projected life expectancy > 10 years, and (3) overall health status without significant comorbidities. [7][8]
Only individuals who are in good health and have no major comorbid conditions meet the health‑status criterion for continued screening. [7][8]

When all three criteria are satisfied, repeat stool‑based testing (annual FIT or Cologuard every 3 years) is preferred over colonoscopy because invasive procedures carry substantially higher risks of perforation, bleeding, and cardiovascular complications in this age group. 7

All CRC screening should be discontinued after age 85 years, irrespective of health status, because the potential harms outweigh any possible benefit beyond this age. [7][8]